Sanmedex SRL
Sanmedex reported total assets of 50,961 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Oct 2026).
The score of Sanmedex shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets 0 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sanmedex's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Oct 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
Sanmedex's financial analysis
- Solvency-75.5%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sanmedex
Sanmedex's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0632.897.878
- VAT number
- BE0632897878
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 30 Jun 2015
- Registered office
- 1180 Uccle
- Latest accounts
- 2025 · filed on 29 Oct 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Sanmedex (SRL) has been based in Uccle since 2015, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 621 € and equity of −38,468 €; its revenue is not published. Its solvency stands at -75.5%, below the median of its sector (32.3%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sanmedex
Companies in the same business, of comparable size and area, outside its group.
- Barette Wholesale of pharmaceutical and medical goods Ixelles · balance sheet 615,019 €
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- SPGL Ltd Wholesale of pharmaceutical and medical goods · balance sheet €1.01m
- Kinergy Wholesale of pharmaceutical and medical goods Assenede · balance sheet 30,483 €
- S.A Therabel-Pharma N.V. Wholesale of pharmaceutical and medical goods Forest · balance sheet €12.8m
- Pharmaceutical industries Advice Wholesale of pharmaceutical and medical goods Rixensart · balance sheet 27,340 €
- Servier Benelux Wholesale of pharmaceutical and medical goods Anderlecht · balance sheet €61.5m
- CONMED Europe Wholesale of pharmaceutical and medical goods Drogenbos · balance sheet €132.2m
Frequently asked questions about Sanmedex
What is the revenue of Sanmedex?
Sanmedex files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sanmedex?
In Belgium, the VAT number is the company number prefixed with BE: BE0632897878 for Sanmedex, if the company is VAT-registered. Its company number (CBE) is 0632.897.878.
Where is the registered office of Sanmedex?
According to the CBE register, the registered office of Sanmedex is in 1180 Uccle.
What is the equity of Sanmedex?
At the close of the 2025 financial year, the equity of Sanmedex amounts to -38,468 €, a solvency of -75.5% of total assets.
Who manages Sanmedex?
The register lists 1 active mandates at Sanmedex. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sanmedex
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →